Literature DB >> 31205917

High-glucose treatment regulates biological functions of human umbilical vein endothelial cells via Sirt1/FOXO3 pathway.

Yihui Chen1, Yan Wang2, Yaping Jiang1, Xiaoyan Zhang3, Minjie Sheng1.   

Abstract

BACKGROUND: Hyperglycaemia-induced angiogenesis plays an important role in diabetic retinopathy (DR). This study aimed to investigate the role of sirtuin1 (Sirt1)/forkhead box O3 (FOXO3) pathway in the effects of high-glucose on human umbilical vein endothelial cells (HUVECs).
METHODS: HUVECs were divided into normal control group (5 mM glucose), high glucose group (30 mM), 30 mM glucose + shsirt1 group, 30 mM glucose + Sirt1 over-expression group (30 mM + Sirt1), 30 mM glucose + Sirt1 agonist SRT group, 30 mM glucose + SRT + FOXO3 silencing group (30 mM + SRT + siFOXO3). Cell proliferation, migration, invasion and apoptosis were determined.
RESULTS: High glucose treatment reduced the expression of Sirt1 and FOXO3 in HUVECs. However, Sirt1 over-expression or SRT attenuated the high-glucose-induced inhibition of HUVEC proliferation and migration as well as reduced their apoptosis. In contrast, Sirt1 silencing deteriorated the high-glucose induced inhibition of HUVEC proliferation and migration and further increased HUVEC apoptosis. FOXO3 expression increased with the increase in Sirt1 expression, which was accompanied by enhanced cellular functions. These were abolished after FOXO3 silencing. In addition, Sirt1/FOXO3 regulated HUVEC activities via peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α).
CONCLUSIONS: Sirt1/FOXO3 pathway is essential for the survival of endothelial cells under high-glucose and plays an important role in the development of diabetes-induced retinal vascular endothelial injury.

Entities:  

Keywords:  Sirtuin1 (Sirt1); forkhead box O3 (FOXO3); hyperglycaemia; peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α); vascular endothelial cells

Year:  2019        PMID: 31205917      PMCID: PMC6545321          DOI: 10.21037/atm.2019.04.29

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  38 in total

1.  Mutual dependence of Foxo3a and PGC-1alpha in the induction of oxidative stress genes.

Authors:  Yolanda Olmos; Inmaculada Valle; Sara Borniquel; Alberto Tierrez; Estrella Soria; Santiago Lamas; Maria Monsalve
Journal:  J Biol Chem       Date:  2009-03-26       Impact factor: 5.157

2.  Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.

Authors:  Anne Brunet; Lora B Sweeney; J Fitzhugh Sturgill; Katrin F Chua; Paul L Greer; Yingxi Lin; Hien Tran; Sarah E Ross; Raul Mostoslavsky; Haim Y Cohen; Linda S Hu; Hwei-Ling Cheng; Mark P Jedrychowski; Steven P Gygi; David A Sinclair; Frederick W Alt; Michael E Greenberg
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

Review 3.  PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Curr Opin Lipidol       Date:  2009-04       Impact factor: 4.776

4.  Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations.

Authors:  Anna Csiszar; Nazar Labinskyy; Andrej Podlutsky; Pawel M Kaminski; Michael S Wolin; Cuihua Zhang; Partha Mukhopadhyay; Pal Pacher; Furong Hu; Rafael de Cabo; Praveen Ballabh; Zoltan Ungvari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-18       Impact factor: 4.733

Review 5.  Silent information regulator, Sirtuin 1, and age-related diseases.

Authors:  Li Zeng; Rui Chen; Fengxia Liang; Hiroshi Tsuchiya; Hiroshi Murai; Takeshi Nakahashi; Kunimitsu Iwai; Takashi Takahashi; Tsugiyasu Kanda; Shigeto Morimoto
Journal:  Geriatr Gerontol Int       Date:  2009-03       Impact factor: 2.730

6.  Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.

Authors:  Jill C Milne; Philip D Lambert; Simon Schenk; David P Carney; Jesse J Smith; David J Gagne; Lei Jin; Olivier Boss; Robert B Perni; Chi B Vu; Jean E Bemis; Roger Xie; Jeremy S Disch; Pui Yee Ng; Joseph J Nunes; Amy V Lynch; Hongying Yang; Heidi Galonek; Kristine Israelian; Wendy Choy; Andre Iffland; Siva Lavu; Oliver Medvedik; David A Sinclair; Jerrold M Olefsky; Michael R Jirousek; Peter J Elliott; Christoph H Westphal
Journal:  Nature       Date:  2007-11-29       Impact factor: 49.962

7.  SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction.

Authors:  Fei Wang; Margaret Nguyen; F Xiao-Feng Qin; Qiang Tong
Journal:  Aging Cell       Date:  2007-05-23       Impact factor: 9.304

8.  SIRT1 controls endothelial angiogenic functions during vascular growth.

Authors:  Michael Potente; Laleh Ghaeni; Danila Baldessari; Raul Mostoslavsky; Lothar Rossig; Franck Dequiedt; Judith Haendeler; Marina Mione; Elisabetta Dejana; Frederick W Alt; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Genes Dev       Date:  2007-10-15       Impact factor: 11.361

9.  Mammalian SIRT1 represses forkhead transcription factors.

Authors:  Maria Carla Motta; Nullin Divecha; Madeleine Lemieux; Christopher Kamel; Delin Chen; Wei Gu; Yvette Bultsma; Michael McBurney; Leonard Guarente
Journal:  Cell       Date:  2004-02-20       Impact factor: 41.582

10.  Leading causes of certification for blindness and partial sight in England & Wales.

Authors:  Catey Bunce; Richard Wormald
Journal:  BMC Public Health       Date:  2006-03-08       Impact factor: 3.295

View more
  11 in total

Review 1.  CircRNA-miRNA interactions in atherogenesis.

Authors:  Kind-Leng Tong; Ke-En Tan; Yat-Yuen Lim; Xin-Yi Tien; Pooi-Fong Wong
Journal:  Mol Cell Biochem       Date:  2022-05-23       Impact factor: 3.396

2.  Scutellaria barbata D. Don Polysaccharides Inhibit High Glucose-Induced Proliferation and Angiogenesis of Retinal Vascular Endothelial Cells.

Authors:  Wenjun Li; Hongxia Xiao
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-31       Impact factor: 3.168

3.  hsa_circ_0058092 protects against hyperglycemia‑induced endothelial progenitor cell damage via miR‑217/FOXO3.

Authors:  Jie Cheng; Weiwei Hu; Fenghui Zheng; Yongfa Wu; Maoquan Li
Journal:  Int J Mol Med       Date:  2020-06-29       Impact factor: 4.101

4.  Dysregulation of miR-210 is involved in the development of diabetic retinopathy and serves a regulatory role in retinal vascular endothelial cell proliferation.

Authors:  Chengyu Yin; Xiangqiang Lin; Yafei Sun; Xinli Ji
Journal:  Eur J Med Res       Date:  2020-05-29       Impact factor: 2.175

5.  SIRT1-Dependent Upregulation of Antiglycative Defense in HUVECs Is Essential for Resveratrol Protection against High Glucose Stress.

Authors:  Silvano Jr Santini; Valeria Cordone; Mahmut Mijit; Virginio Bignotti; Pierpaolo Aimola; Vincenza Dolo; Stefano Falone; Fernanda Amicarelli
Journal:  Antioxidants (Basel)       Date:  2019-09-01

6.  Roles of Endovascular Calyx Related Enzymes in Endothelial Dysfunction and Diabetic Vascular Complications.

Authors:  Zhi Li; Ning Wu; Jing Wang; Quanbin Zhang
Journal:  Front Pharmacol       Date:  2020-11-30       Impact factor: 5.810

Review 7.  Longevity Factor FOXO3: A Key Regulator in Aging-Related Vascular Diseases.

Authors:  Yan Zhao; You-Shuo Liu
Journal:  Front Cardiovasc Med       Date:  2021-12-23

8.  Metformin alleviates bevacizumab-induced vascular endothelial injury by up-regulating GDF15 and activating the PI3K/AKT/FOXO/PPARγ signaling pathway.

Authors:  Liqiang Chen; Yajuan Yin; Gang Liu
Journal:  Ann Transl Med       Date:  2021-10

9.  Vitamin D Prevents High Glucose-Induced Lipid Droplets Accumulation in Cultured Endothelial Cells: The Role of Thioredoxin Interacting Protein.

Authors:  Roberta Scrimieri; Alessandra Cazzaniga; Sara Castiglioni; Jeanette A M Maier
Journal:  Biomedicines       Date:  2021-12-10

10.  LncRNA HCG11/miR-26b-5p/QKI5 feedback loop reversed high glucose-induced proliferation and angiogenesis inhibition of HUVECs.

Authors:  Jiao Du; Ruijuan Han; Yihua Li; Xiaolin Liu; Shurong Liu; Zhenyu Cai; Zhaolong Xu; Ya Li; Xuchun Yuan; Xiuhai Guo; Bin Lu; Kai Sun
Journal:  J Cell Mol Med       Date:  2020-10-30       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.